Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 384

1.

Coasting vs. cryopreservation of all embryos for prevention of ovarian hyperstimulation syndrome in in vitro fertilization.

Huddleston HG, Racowsky C, Jackson KV, Fox JH, Ginsburg ES.

Fertil Steril. 2008 Oct;90(4):1259-62. doi: 10.1016/j.fertnstert.2007.07.1383. Epub 2007 Dec 27.

PMID:
18163999
2.

Elective cryopreservation of all embryos with subsequent cryothaw embryo transfer in patients at risk for ovarian hyperstimulation syndrome reduces the risk of adverse obstetric outcomes: a preliminary study.

Imudia AN, Awonuga AO, Kaimal AJ, Wright DL, Styer AK, Toth TL.

Fertil Steril. 2013 Jan;99(1):168-73. doi: 10.1016/j.fertnstert.2012.08.060. Epub 2012 Sep 29.

PMID:
23025881
3.

Vitrification is a highly efficient method to cryopreserve human embryos in in vitro fertilization patients at high risk of developing ovarian hyperstimulation syndrome.

Selman H, Brusco GF, Fiorini F, Barnocchi N, Mariani M, El-Danasouri I.

Fertil Steril. 2009 Apr;91(4 Suppl):1611-3. doi: 10.1016/j.fertnstert.2008.12.027. Epub 2009 Feb 6.

PMID:
19200960
4.

[Incidence of ovarian hyperstimulation syndrome in in-vitro-fertilization treatment over a period of 11 years].

Niederberger V, Rottensteiner-Grohsmann C, Turnheim K, Obruca A, Brunner M, Feichtinger W.

Wien Med Wochenschr. 1995;145(23):642-5. German.

PMID:
8578756
5.

Elective cryopreservation of embryos at the pronucleate stage in women at risk of ovarian hyperstimulation syndrome may affect the overall pregnancy rate.

Vyjayanthi S, Tang T, Fattah A, Deivanayagam M, Bardis N, Balen AH.

Fertil Steril. 2006 Dec;86(6):1773-5. Epub 2006 Sep 29.

PMID:
17011557
6.

The effect of cryopreservation in prevention of ovarian hyperstimulation syndrome.

Tiitinen A, Husa LM, Tulppala M, Simberg N, Seppälä M.

Br J Obstet Gynaecol. 1995 Apr;102(4):326-9.

PMID:
7612517
7.

Does elective cryopreservation of all embryos from women at risk of ovarian hyperstimulation syndrome reduce the incidence of the condition?

Wada I, Matson PL, Troup SA, Morroll DR, Hunt L, Lieberman BA.

Br J Obstet Gynaecol. 1993 Mar;100(3):265-9. Erratum in: Br J Obstet Gynaecol 1993 Jun;100(6):535.

PMID:
8476833
8.

Impact of fresh-cycle variables on the implantation potential of cryopreserved-thawed human embryos.

Urman B, Balaban B, Yakin K.

Fertil Steril. 2007 Feb;87(2):310-5. Epub 2006 Nov 13.

PMID:
17097088
9.

Day 2 transfer improves pregnancy outcome in in vitro fertilization cycles with few available embryos.

Shen S, Rosen MP, Dobson AT, Fujimoto VY, McCulloch CE, Cedars MI.

Fertil Steril. 2006 Jul;86(1):44-50. Epub 2006 May 30.

PMID:
16730718
10.

Ovarian hyperstimulation syndrome: steps to maximize success and minimize effect for assisted reproductive outcome.

Gera PS, Tatpati LL, Allemand MC, Wentworth MA, Coddington CC.

Fertil Steril. 2010 Jun;94(1):173-8. doi: 10.1016/j.fertnstert.2009.02.049. Epub 2009 Apr 7.

PMID:
19356753
11.

Correctly timed coasting reduces the risk of ovarian hyperstimulation syndrome and gives good cycle outcome in an in vitro fertilization program.

Grochowski D, Wołczyński S, Kuczyński W, Domitrz J, Szamatowicz J, Szamatowicz M.

Gynecol Endocrinol. 2001 Jun;15(3):234-8.

PMID:
11447736
12.

Elective cryopreservation of all pronucleate embryos in women at risk of ovarian hyperstimulation syndrome: efficiency and safety.

Ferraretti AP, Gianaroli L, Magli C, Fortini D, Selman HA, Feliciani E.

Hum Reprod. 1999 Jun;14(6):1457-60.

PMID:
10357958
14.

Avoiding the use of human chorionic gonadotropin combined with oocyte vitrification and GnRH agonist triggering versus coasting: a new strategy to avoid ovarian hyperstimulation syndrome.

Herrero L, Pareja S, Losada C, Cobo AC, Pellicer A, Garcia-Velasco JA.

Fertil Steril. 2011 Mar 1;95(3):1137-40. doi: 10.1016/j.fertnstert.2010.09.040. Epub 2010 Nov 3.

PMID:
21047635
15.

Perinatal and neonatal outcomes of 494 babies delivered from 972 vitrified embryo transfers.

Shi W, Xue X, Zhang S, Zhao W, Liu S, Zhou H, Wang M, Shi J.

Fertil Steril. 2012 Jun;97(6):1338-42. doi: 10.1016/j.fertnstert.2012.02.051. Epub 2012 Mar 30.

PMID:
22464083
16.

Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.

Moon HS, Joo BS, Moon SE, Lee SK, Kim KS, Koo JS.

Fertil Steril. 2008 Dec;90(6):2172-8. doi: 10.1016/j.fertnstert.2007.10.033. Epub 2008 Apr 25.

PMID:
18439601
17.

The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization.

Nardo LG, Cheema P, Gelbaya TA, Horne G, Fitzgerald CT, Pease EH, Brison DR, Lieberman BA.

Hum Fertil (Camb). 2006 Sep;9(3):175-80.

PMID:
17008270
19.
20.

Supplemental Content

Support Center